Skip to Content

Almirall SA ALM

Morningstar Rating
€8.27 +0.05 (0.61%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ALM is trading within a range we consider fairly valued.
Price
€8.01
Fair Value
€9.86
Uncertainty
High
1-Star Price
€47.22
5-Star Price
€4.55
Economic Moat
Ctm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALM is a good fit for your portfolio.

News

Trading Information

Previous Close Price
€8.22
Day Range
€8.088.30
52-Week Range
€7.1610.08
Bid/Ask
/
Market Cap
€1.73 Bil
Volume/Avg
196,575 / 185,497

Key Statistics

Price/Earnings (Normalized)
178.69
Price/Sales
1.82
Dividend Yield (Trailing)
2.23%
Dividend Yield (Forward)
2.23%
Total Yield
2.24%

Company Profile

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company’s operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
1,885

Comparables

Valuation

Metric
ALM
BEACONPHAR
RJF
Price/Earnings (Normalized)
178.6971.721.14
Price/Book Value
1.187.240.96
Price/Sales
1.824.870.62
Price/Cash Flow
11.556.39
Price/Earnings
ALM
BEACONPHAR
RJF

Financial Strength

Metric
ALM
BEACONPHAR
RJF
Quick Ratio
1.520.390.76
Current Ratio
2.051.221.47
Interest Coverage
−2.161.7615.00
Quick Ratio
ALM
BEACONPHAR
RJF

Profitability

Metric
ALM
BEACONPHAR
RJF
Return on Assets (Normalized)
0.05%4.32%3.73%
Return on Equity (Normalized)
0.08%10.35%6.19%
Return on Invested Capital (Normalized)
0.13%9.14%5.00%
Return on Assets
ALM
BEACONPHAR
RJF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class APtzztqcdcSsmh$77.5 Bil
MKKGY
Merck KGaA ADRSssqktwjlHdfkpy$76.9 Bil
HLN
Haleon PLC ADRBcjzptgwWsd$38.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRYrnztpyNxq$15.9 Bil
VTRS
Viatris IncSvlzqvhqKtdnm$14.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYlksqkygjHhpww$12.3 Bil
CTLT
Catalent IncYkxvfzndKrfff$10.2 Bil
PRGO
Perrigo Co PLCChhxdylhKzvfz$4.4 Bil
CURLF
Curaleaf Holdings IncRrhwrwjxkPmndc$3.9 Bil
PBH
Prestige Consumer Healthcare IncWldbxjjgMytvm$3.6 Bil

Sponsor Center